female scientist performing test with pipette in laboratory setting
Scientist in laboratory setting (symbolic photo)

Image source: Unsplash/Julia Koblitz

Early detection of coronavirus presence

Covid-19 wastewater testing: new quantification kit launched

Life science research and clinical diagnostics company Bio-Rad Laboratories announced the launch of its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit, a tool to detect the virus that causes Covid-19 in a community’s wastewater.

"With wastewater testing becoming more widely adopted, this assay provides the ability for a community to determine if the virus is present days to weeks before the virus may be detected in individuals," said Simon May, Bio-Rad Senior Vice President, Digital Biology Group. "As we continue to manage the spread of Covid-19, it is especially important to have a highly sensitive early warning system that can be implemented on a community-wide basis," he said. ddPCR technology is recommended in the Centers for Disease Control and Prevention guidelines (CDC) for wastewater testing, and use of the technology has been published by the Environmental Protection Agency (EPA) as a dependable method to quantify viruses in wastewater.

The PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit includes all reagents needed to detect the virus in wastewater along with software for automated analysis. The test runs on Bio-Rad's QX200 Droplet Digital PCR System, QX200 AutoDG Droplet Digital PCR System, and the QX ONE Droplet Digital PCR System. It joins Bio-Rad's menu of Covid-19 products that are being used in the global fight against Covid-19. Other products include molecular qPCR and ddPCR instruments and assays, antibody tests, quality controls, and ddPCR assays to detect SARS-CoV-2 variants of concern.

Source: Bio-Rad Laboratories 


Read all latest stories

Related articles


Coronavirus protein and antibody detection

Bioluminescence lights up traces of Covid-19 in the blood

Home test kits to check for Covid-19 spike proteins and anti-Covid-19 antibodies are fast and simple to use but lack the sensitivity and accuracy of laboratory tests. Researchers from Eindhoven…


Sample-to-answer workflow

Partnership for Covid-19 test solution

SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The…


Detecting Coronavirus

AI vs. Covid-19: ‘Barcode’ brings quicker test results

When patients are admitted to a hospital emergency room (ER) it is immediately vital to determine whether s/he has Covid-19. However, with a regular PCR test a result can take up to a few hours.…

Related products

Subscribe to Newsletter